Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Technology › Novo Nordisk (NVO) Taps Anthropic AI to Develop...
Technology

Novo Nordisk (NVO) Taps Anthropic AI to Develop Next-Generation Medicines

Bloomberg Technology Thursday 17 September 2026, 10:30 UTC By Naomi Kresge 1 min read
Key Points

The Ozempic maker sees a need for speed when it comes to AI

The Ozempic maker sees a need for speed when it comes to AI
Novo Nordisk (ORG) NVO (ORG) Develop Next-Generation Medicines The Ozempic (ORG)
Originally published by Bloomberg Technology Read original →

Related Stories

Test environment let anyone access live customer data

PWNED Welcome back to PWNED, the weekly column where we learn important life lessons about how we let cybercrims access our data through carelessness. Hopefully, others’ mistakes provide an example of what not to do. Today’s tales of woe comes courtesy of Richard Schut, Managing Director & AI Software Researcher at SmartRepl, a company that offers business AI services such as AI receptionists and sales automation.

The Register 7m ago

EU’s Slow Regulation Is Finding Fans in AI Age

As the need for safety and restraint rises, Europe could help lead the way

Bloomberg Technology 33m ago

Labor crisis in U.S. chip manufacturing leaves Samsung, TSMC desperate for talent

As AI companies propose slowing down model development on concerns about the technology's rapid and scary advancements, another issue on the hardware side of the industry might be forcing them to decelerate. Manpower is at the heart of the world's ability to make enough chips to power artificial intelligence, and the U.S. now faces a shortage of up to 157,000 semiconductor workers by 2030, according to a new report from McKinsey and the SEMI Foundation. "I'm concerned," said Jon Taylor,...

CNBC 35m ago

Soundboks Rider Party Speaker Review: Loud and Durable

Gets very loud for its size. Clear, detailed sound. IP66 dust and waterproof.

Wired 35m ago